Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Acta Psychiatr Scand
    November 2024
  1. ODSBU I, Hamina A, Hjellvik V, Handal M, et al
    Initiation of Antipsychotics During the First Year After First-Episode Psychosis: A Population-Based Study.
    Acta Psychiatr Scand. 2024 Nov 29. doi: 10.1111/acps.13776.
    >> Share

  2. TAHMAZOV E, Bosse J, Glemain B, Nabbe P, et al
    Impact of Early Intervention for Early Psychosis on Suicidal Behavior-A Meta-Analysis.
    Acta Psychiatr Scand. 2024 Nov 27. doi: 10.1111/acps.13773.
    >> Share

  3. D'ANDREA G, Quattrone D, Tripoli G, Spinazzola E, et al
    Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study.
    Acta Psychiatr Scand. 2024 Nov 1. doi: 10.1111/acps.13767.
    >> Share

    October 2024
  4. MADSEN NM, Sorensen MA, Danielsen AA, Hojlund M, et al
    The risk of diabetes and HbA1c deterioration during antipsychotic drug treatment: A Danish two-cohort study among patients with first-episode schizophrenia.
    Acta Psychiatr Scand. 2024 Oct 8. doi: 10.1111/acps.13760.
    >> Share

    September 2024
  5. VAN OPSTAL DPJ, Kia SM, Jakob L, Somers M, et al
    Psychosis Prognosis Predictor: A continuous and uncertainty-aware prediction of treatment outcome in first-episode psychosis.
    Acta Psychiatr Scand. 2024 Sep 18. doi: 10.1111/acps.13754.
    >> Share

  6. COHN AB, Yang YS
    The effects of individualism versus collectivism on clozapine policy stringency.
    Acta Psychiatr Scand. 2024;150:180-181.
    >> Share

    August 2024
  7. KEINANEN J, Eskelinen S, From T, Laurikainen H, et al
    Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in Finland.
    Acta Psychiatr Scand. 2024 Aug 29. doi: 10.1111/acps.13752.
    >> Share

  8. LIN YP, Chen WY, Pan CH, Su SS, et al
    Age-stratified risk of suicide in patients with schizophrenia.
    Acta Psychiatr Scand. 2024 Aug 14. doi: 10.1111/acps.13747.
    >> Share

  9. AMBROSEN KS, Lemvigh CK, Nielsen MO, Glenthoj BY, et al
    Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naive patients with first-episode psychosis.
    Acta Psychiatr Scand. 2024 Aug 12. doi: 10.1111/acps.13743.
    >> Share

    July 2024
  10. SASS MR, Christensen AMB, Christensen ML, Gruber E, et al
    Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study.
    Acta Psychiatr Scand. 2024;150:35-47.
    >> Share

    June 2024
  11. BERKHOF M, van der Stouwe ECD, Pot-Kolder RMCA, van der Gaag M, et al
    Exploring the role of clinical and demographic characteristics on the effects of virtual reality cognitive behavioral therapy for psychosis: A moderator analysis.
    Acta Psychiatr Scand. 2024 Jun 9. doi: 10.1111/acps.13713.
    >> Share

    April 2024
  12. CLARK I, Wallman P, Gee S, Taylor D, et al
    Long term impact of 3-monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six-year mirror image study.
    Acta Psychiatr Scand. 2024 Apr 15. doi: 10.1111/acps.13691.
    >> Share

  13. DALAL TC, Liang L, Silva AM, Mackinley M, et al
    Speech based natural language profile before, during and after the onset of psychosis: A cluster analysis.
    Acta Psychiatr Scand. 2024 Apr 10. doi: 10.1111/acps.13685.
    >> Share

    February 2024
  14. BERGQVIST J, Hedskog S, Hedman C, Schultz T, et al
    Patients with both cancer and psychosis-to what extent do they receive specialized palliative care.
    Acta Psychiatr Scand. 2024 Feb 18. doi: 10.1111/acps.13666.
    >> Share

  15. TSUKAHARA M, So R, Yoshimura Y, Nakajima S, et al
    Response to the letter to the Editor from Araujo and colleagues on the research article entitled, "Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year r
    Acta Psychiatr Scand. 2024 Feb 15. doi: 10.1111/acps.13674.
    >> Share

    January 2024
  16. ARAUJO MB, Nogueira GN, Silveira PLSD, de Souza Junior SA, et al
    Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment-resistant schizophrenia.
    Acta Psychiatr Scand. 2024 Jan 23. doi: 10.1111/acps.13659.
    >> Share

  17. DREVINSKAITE M, Kaceniene A, Patasius A, Stukas R, et al
    Cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
    Acta Psychiatr Scand. 2024 Jan 3. doi: 10.1111/acps.13651.
    >> Share

    December 2023
  18. EDVARDSEN E, Moszkowicz M, Olsen AL, Heinrichsen M, et al
    Clinical and sociodemographic features in offspring aged 0-3 years of mothers with schizophrenia spectrum disorders. A descriptive cross-sectional study.
    Acta Psychiatr Scand. 2023 Dec 10. doi: 10.1111/acps.13641.
    >> Share

  19. OLOYEDE E, Dima A, Taylor D, Cheung H, et al
    Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review.
    Acta Psychiatr Scand. 2023;148:538-552.
    >> Share

    November 2023
  20. JOHN AP, Mya T, Haywood D
    Cognitive deficits among people with schizophrenia and prediabetes or diabetes.
    Acta Psychiatr Scand. 2023 Nov 10. doi: 10.1111/acps.13627.
    >> Share

    September 2023
  21. TSUKAHARA M, So R, Yoshimura Y, Yamashita R, et al
    Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
    Acta Psychiatr Scand. 2023 Sep 8. doi: 10.1111/acps.13612.
    >> Share

    August 2023
  22. CHENG CS, Chen WY, Chang HM, Pan CH, et al
    Unfavorable cancer mortality-to-incidence ratios in patients with schizophrenia: A nationwide cohort study in Taiwan, 2000-2019.
    Acta Psychiatr Scand. 2023 Aug 21. doi: 10.1111/acps.13604.
    >> Share

  23. VOCHOSKOVA K, McWhinney SR, Fialova M, Kolenic M, et al
    Weight and metabolic changes in early psychosis-association with daily quantification of medication exposure during the first hospitalization.
    Acta Psychiatr Scand. 2023 Aug 1. doi: 10.1111/acps.13594.
    >> Share

    May 2023
  24. KOHLER-FORSBERG O, Antonsen S, Pedersen CB, Mortensen PB, et al
    Schizophrenia spectrum disorders in Denmark between 2000 and 2018: Incidence and early diagnostic transition.
    Acta Psychiatr Scand. 2023 May 26. doi: 10.1111/acps.13565.
    >> Share

    April 2023
  25. ALLEBECK P, Gunnarsson T, Lundin A, Lofving S, et al
    Does a history of cannabis use influence onset and course of schizophrenia?
    Acta Psychiatr Scand. 2023 Apr 24. doi: 10.1111/acps.13562.
    >> Share

    March 2023
  26. VALLI I, Segura AG, Verdolini N, Garcia-Rizo C, et al
    Obstetric complications and genetic risk for schizophrenia: differential role of antenatal and perinatal events in first episode psychosis.
    Acta Psychiatr Scand. 2023 Mar 13. doi: 10.1111/acps.13546.
    >> Share

  27. WILLIAMS TF, Walker EF, Strauss GP, Woods SW, et al
    The reliability and validity of the Revised Green et al. Paranoid Thoughts Scale in individuals at clinical high-risk for psychosis.
    Acta Psychiatr Scand. 2023 Mar 11. doi: 10.1111/acps.13545.
    >> Share

    December 2022
  28. LI Z, Wang Y, Wang Z, Kong L, et al
    Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Acta Psychiatr Scand. 2022 Dec 30. doi: 10.1111/acps.13530.
    >> Share

    September 2022
  29. SANCHEZ-GUTIERREZ T, Barbeito S, Gomez-Juncal R, Rodriguez-Ortega E, et al
    Neuropsychological Functioning and Suicidal Behaviours in Patients with First-Episode Psychosis: A Systematic Review.
    Acta Psychiatr Scand. 2022 Sep 25. doi: 10.1111/acps.13501.
    >> Share

  30. PURANEN A, Koponen M, Lahteenvuo M, Tanskanen A, et al
    Real-world effectiveness of mood stabilizer use in schizophrenia.
    Acta Psychiatr Scand. 2022 Sep 5. doi: 10.1111/acps.13498.
    >> Share

  31. STOGIOS N, Maksyutynska K, Navagnanavel J, Sanches M, et al
    Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort study.
    Acta Psychiatr Scand. 2022;146:190-200.
    >> Share

    July 2022
  32. GYLLENBERG D, Ristikari T, Kelleher I, Kaariala A, et al
    School Performance and Later Diagnoses of Non-Affective Psychoses, Bipolar Disorder and Depression.
    Acta Psychiatr Scand. 2022 Jul 25. doi: 10.1111/acps.13481.
    >> Share

  33. BENROS ME
    High-quality large-scale longitudinal studies with detailed multimodal immunological phenotyping are warranted to disentangle the involvement of the immune system in psychosis.
    Acta Psychiatr Scand. 2022;146:3-5.
    >> Share

    May 2022
  34. FACAL F, Arrojo M, Paz E, Paramo M, et al
    Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics.
    Acta Psychiatr Scand. 2022 May 18. doi: 10.1111/acps.13444.
    >> Share

    April 2022
  35. BAANDRUP L, Allerup P, Nielsen MO, During SW, et al
    Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models.
    Acta Psychiatr Scand. 2022 Apr 13. doi: 10.1111/acps.13434.
    >> Share

    March 2022
  36. SPILKA MJ, Keller WR, Buchanan RW, Gold JM, et al
    Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia.
    Acta Psychiatr Scand. 2022 Mar 4. doi: 10.1111/acps.13421.
    >> Share

    February 2022
  37. DUNLEAVY C, Elsworthy RJ, Upthegrove R, Wood SJ, et al
    Inflammation in First-Episode Psychosis: The Contribution of Inflammatory Biomarkers to the Emergence of Negative Symptoms, A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2022 Feb 24. doi: 10.1111/acps.13416.
    >> Share

  38. MORENO-KUSTNER B, Fabrega-Ruz J, Gonzalez-Caballero JL, Reyes S, et al
    The Patient-Reported Impact of Symptoms in Schizophrenia Scale (PRISS): Development and Validation.
    Acta Psychiatr Scand. 2022 Feb 21. doi: 10.1111/acps.13417.
    >> Share

  39. VERDOLINI N, Borras R, Sparacino G, Garriga M, et al
    The prodromal phase: Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood.
    Acta Psychiatr Scand. 2022 Feb 16. doi: 10.1111/acps.13415.
    >> Share

  40. BRODEUR S, Vanasse A, Courteau J, Stip E, et al
    Comparative Effectiveness and Safety of Antipsychotic Drugs in Patients with Schizophrenia Initiating or Reinitiating Treatment: A Real-World Observational Study.
    Acta Psychiatr Scand. 2022 Feb 14. doi: 10.1111/acps.13413.
    >> Share

  41. TESLI M, Degerud E, Plana-Ripoll O, Gustavson K, et al
    Educational attainment and mortality in schizophrenia.
    Acta Psychiatr Scand. 2022 Feb 13. doi: 10.1111/acps.13407.
    >> Share

  42. BRODEUR S, Vanasse A, Courteau J, Courteau M, et al
    Antipsychotic Utilization Trajectories Three Years After Initiating or Reinitiating Treatment of Schizophrenia: A State Sequence Analysis Approach.
    Acta Psychiatr Scand. 2022 Feb 12. doi: 10.1111/acps.13411.
    >> Share

    January 2022
  43. MURILLO-GARCIA N, Diaz-Pons A, Fernandez-Cacho LM, Miguel-Cossrredera M, et al
    A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype.
    Acta Psychiatr Scand. 2022 Jan 25. doi: 10.1111/acps.13404.
    >> Share

  44. BALLESTER PL, Romano MT, de Azevedo Cardoso T, Hassel S, et al
    Brain age in mood and psychotic disorders: a systematic review and meta-analysis.
    Acta Psychiatr Scand. 2022;145:42-55.
    >> Share

    December 2021
  45. LOPEZ-DIAZ A, Ayesa-Arriola R, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, et al
    Predictors of diagnostic stability in brief psychotic disorders: Findings from a 3-year longitudinal study.
    Acta Psychiatr Scand. 2021;144:578-588.
    >> Share

    November 2021
  46. NIELSEN J
    Clozapine treatment in a wider context: From before eligibility to life beyond clozapine.
    Acta Psychiatr Scand. 2021;144:419-421.
    >> Share

  47. SISKIND D, Sharma M, Pawar M, Pearson E, et al
    Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis.
    Acta Psychiatr Scand. 2021;144:422-432.
    >> Share

    October 2021
  48. MUSTAFA SS, Malla A, Joober R, Abadi S, et al
    Unfinished business: Functional outcomes in a randomized controlled trial of a three-year extension of early intervention versus regular care following two years of early intervention for psychosis.
    Acta Psychiatr Scand. 2021 Oct 2. doi: 10.1111/acps.13377.
    >> Share

    September 2021
  49. PARK CI, Han M, Jung I, Kim EH, et al
    A nationwide nested case-control study of new-onset obsessive-compulsive disorder following antipsychotics use in schizophrenia.
    Acta Psychiatr Scand. 2021 Sep 26. doi: 10.1111/acps.13375.
    >> Share

    August 2021
  50. SMITH E, Singh R, Lee J, Colucci L, et al
    Adiposity in Schizophrenia: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Aug 30. doi: 10.1111/acps.13365.
    >> Share

  51. KRISTENSEN TD, Glenthoj LB, Ambrosen K, Syeda W, et al
    Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra-high risk for psychosis.
    Acta Psychiatr Scand. 2021 Aug 1. doi: 10.1111/acps.13355.
    >> Share

  52. HSU CW, Tseng PT, Tu YK, Lin PY, et al
    Month of birth and mental disorders: A population-based study and validation using global meta-analysis.
    Acta Psychiatr Scand. 2021;144:153-167.
    >> Share

    July 2021
  53. FUJIWARA M, Yamada Y, Shimazu T, Kodama M, et al
    Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial.
    Acta Psychiatr Scand. 2021 Jul 9. doi: 10.1111/acps.13348.
    >> Share

  54. SUAREZ-PINILLA P, Suarez-Pinilla M, Setien-Suero E, Ortiz-Garcia de la Foz V, et al
    Stability of schizophrenia diagnosis in a ten-year longitudinal study on first episode of non-affective psychosis: conclusions from the PAFIP cohort.
    Acta Psychiatr Scand. 2021 Jul 6. doi: 10.1111/acps.13344.
    >> Share

  55. BARCELLA CA, Polcwiartek C, Mohr GH, Hodges G, et al
    Severe mental illness is associated with increased mortality and severe course of COVID-19.
    Acta Psychiatr Scand. 2021;144:82-91.
    >> Share

    June 2021
  56. BHAVSAR V, Kepinska AP
    Schizophrenia, catatonic schizophrenia and poliovirus - a role for natural experiments?
    Acta Psychiatr Scand. 2021;143:469-471.
    >> Share

    May 2021
  57. SHOHAM N, Eskinazi M, Hayes JF, Lewis G, et al
    Associations Between Psychosis and Visual Acuity Impairment: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 May 24. doi: 10.1111/acps.13330.
    >> Share

    April 2021
  58. MARWAHA S, Hett D, Johnson S, Fowler D, et al
    The impact of manic symptoms in first-episode psychosis: findings from the UK National EDEN study.
    Acta Psychiatr Scand. 2021 Apr 16. doi: 10.1111/acps.13307.
    >> Share

  59. SANKARANARAYANAN A, Pratt R, Anoop A, Smith A, et al
    Serum Lipids and Suicidal Risk among Patients with Schizophrenia Spectrum Disorders: Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Apr 9. doi: 10.1111/acps.13305.
    >> Share

  60. WHISKEY E, Barnard A, Oloyede E, Dzahini O, et al
    An evaluation of the variation and underuse of clozapine in the United Kingdom.
    Acta Psychiatr Scand. 2021;143:339-347.
    >> Share

    March 2021
  61. VAN DER ZALM Y, Foldager L, Termorshuizen F, Sommer IE, et al
    Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study.
    Acta Psychiatr Scand. 2021;143:216-226.
    >> Share

  62. YADA Y, Kitagawa K, Sakamoto S, Ozawa A, et al
    The relationship between plasma clozapine concentration and clinical outcome: a cross-sectional study.
    Acta Psychiatr Scand. 2021;143:227-237.
    >> Share

    March 2020
  63. KAROW A, Brettschneider C, Helmut Konig H, Correll CU, et al
    Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis.
    Acta Psychiatr Scand. 2020;141:221-230.
    >> Share

  64. RUBIO JM, Kane JM
    How and when to use clozapine.
    Acta Psychiatr Scand. 2020;141:178-189.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016